Inactive Total Small Business Set-Aside (FAR 19.5)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) requires a contractor to generate a custom Single-Domain Antibody targeting the human Calcium-Sensing Receptor for use in parathyroid tumor imaging and treatment. The contractor must deliver 0.5 to 1 mg each of four purified, validated, and 3XFLAG-tagged sdAb clones, along with four DNA minipreps and complete sequence information. Performance of the services will take place in Bethesda, MD. The contract will be awarded as a Firm Fixed Price, with technical and past performance factors considered significantly more important than cost. The closing response date for proposals is May 24, 2026, at 9:00 AM Eastern Daylight Time.